HeartBeam is addressing limitations of traditional 12-lead electrocardiogram systems, which often involve cumbersome setups and restricted accessibility. The company is developing the HeartBeam System, described as the first cable-free, high-fidelity ECG system that captures the heart's electrical signals from three distinct directions and synthesizes the signals into a 12-lead ECG. This capability enables comprehensive arrhythmia assessment outside clinical settings, potentially revolutionizing cardiac care by providing patients with convenient and accurate heart health monitoring.
The system's design emphasizes user friendliness and portability, with the device being the size of a credit card. This compact form factor makes it easy for patients to use at home or while traveling. Patients can capture their ECG by placing the device on their chest for 30 seconds, after which the data is transmitted securely to an on-call cardiologist for review. This streamlined process enables timely interventions when necessary, addressing a critical gap in current cardiac care approaches.
HeartBeam is creating what it describes as the first-ever cable-free 12-lead ECG capable of capturing the heart's electrical signals from three dimensions. This platform technology is designed for use in portable devices that can be utilized wherever the patient is located to deliver actionable heart intelligence. Physicians will be able to identify cardiac health trends and acute conditions and direct patients to appropriate care outside of medical facilities, potentially redefining the future of cardiac health management.
The company holds significant intellectual property protection for its technology, with 13 U.S. and 4 international-issued patents related to technology enablement. For more detailed information about the company and its technology, visit https://www.HeartBeam.com. Additional context about the technology and its development can be found in the full article available at https://nnw.fm/KrqTd. The innovative approach represents a significant advancement in making comprehensive cardiac monitoring accessible beyond traditional healthcare settings, potentially improving early detection and management of heart conditions.
